Kindly MD Inc

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Kindly MD, Inc. provides healthcare services. Its services include medication management, behavioral healthcare and alternative treatments. The firm offers evaluation and management, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy. The company was founded by Timothy Pickett in December 2019 and is headquartered in Murray, UT.

KindlyMD now provides more than 90% statewide comprehensive insurance coverage SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced it is now contracted with Cigna Healthcare, after receiving additional credentialing. Cigna's innovative approach to behavioral health focuses on integrating mental health services with primary care and ensuring that individuals receive comprehensive support tailored to their unique needs.

KindlyMD(R) Announces New Partnership With Cigna Healthcare to Further Expand Patient Care Accessibility

SALT LAKE CITY, UT / ACCESSWIRE / September 12, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced it has been recognized as one of the winners of the Healthcare AI Impact Award 2024. This award spotlights the most forward-thinking companies in healthcare, driving real improvements in patient care and operational efficiency through the use of artificial intelligence.

KindlyMD(TM) Recognized with Healthcare AI Impact Award 2024

Ms. Pratt, a seasoned mental health counselor with extensive academic and practical experience, will enhance the Company's Complete Care and Therapy services SALT LAKE CITY, UT / ACCESSWIRE / August 22, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, is pleased to announce the appointment of Nancy Pratt, a clinical mental health counselor (CMHC), as Behavioral Health Program Director. Ms. Pratt will bolster the KindlyMD leadership team, driving the Company's Complete Care and Therapy services as a key part of their strategic mission to offer comprehensive, Complete Care programs for patients.

KindlyMD(TM) Appoints Nancy Pratt as Behavioral Health Program Director

Company provides nearly 80% statewide comprehensive insurance coverage in Utah under contract with providers such as Medicare, Select Health, Medicaid, and Blue Cross Blue Shield Reimbursement from insurance payors increased 163.7% sequentially and is expected to increase as a percentage of total revenue going forward Reimbursements from insurance payors totaled $126,325 in first half of 2024 as compared to $0 during the first half of 2023 SALT LAKE CITY, UT / ACCESSWIRE / August 14, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced its financial results for the second quarter ended June 30, 2024 and is providing a shareholder update. Tim Pickett, PA-C, KindlyMD Founder and CEO, stated, "During the second quarter we successfully closed on our IPO for gross proceeds of approximately $6 million.

KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update

SALT LAKE CITY, UT / ACCESSWIRE / August 13, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, is pleased to announce that management is scheduled to participate in the following August 2024 conferences. Sidoti Micro-Cap Virtual Conference Presentation Date and Time: Wednesday, August 14th at 11:30 a.m.

KindlyMD to Present at Upcoming August 2024 Investor Conferences

SALT LAKE CITY, UT / ACCESSWIRE / July 25, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, announced today that it has submitted a comment to the U.S. Department of Justice, following its recent proposed rule to reclassify cannabis from Schedule I to Schedule III of the Controlled Substances Act ("CSA"), consistent with the view of the Department of Health and Human Services ("HHS") that cannabis has a currently accepted medical use as well as HHS's views concerning cannabis abuse potential and the level of physical or psychological dependence. For the past 54 years, cannabis has been categorized as a Schedule I controlled substance under the Controlled Substances Act.

KindlyMD(TM) Submits Comment to the Department of Justice Regarding Cannabis Rescheduling

Tilray Brands

Valley National

With the federal government moving to reschedule cannabis to Schedule III, effectively paving the way for medical cannabis legalization, cannabis stocks are in the spotlight. Cannabis stocks initially spiked on the news but quickly returned to previous levels.

3 Cannabis Stocks to Buy at a 52-Week Low in July

Proficient Auto Logistics Inc

Viking Holdings Ltd

Though Reddit (NYSE: RDDT ) may have been the most recent big-name IPO, the initial listings market is still cooking, and undervalued IPO stocks abound. The last undervalued IPO stock I picked at the beginning of June, Nano Nuclear Energy (NASDAQ: NNE ), returned over 300% since I first noticed it, further proving that undervalued IPO stocks are out there if you know where to look.

3 IPO Gems Flying Under the Radar (for Now)

KindlyMD is now providing nearly 80% statewide comprehensive insurance coverage SALT LAKE CITY, UT / ACCESSWIRE / June 17, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced it has received additional credentialing and is now proudly contracted with Blue Cross Blue Shield under Utah's top insurance payors. The Company recently announced it became one of the first alternative medical treatment companies in the state to receive this status, with the contracts of Select Health, Medicare, and Medicaid.

KindlyMD(TM) is Proudly Contracted with Blue Cross Blue Shield Under Utah's Top Insurance Payors

Curaleaf Holdings, Inc.

Community care events to be held throughout summer at Curaleaf's Lehi, Provo, and Payson, Utah Medical Cannabis Pharmacies SALT LAKE CITY, UT / ACCESSWIRE / June 10, 2024 / KindlyMD, Inc. ("KindlyMD" or "the Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced a strategic collaboration with Curaleaf Holdings, Inc. (TSX:CURA)(OTCQX:CURLF) ("Curaleaf"), a leading international provider of consumer products in cannabis. Under the terms of the collaboration, KindlyMD and Curaleaf will work together to provide educational resources and information with a community perspective on holistic pain management and treatment.

KindlyMD(TM) Collaborates with Curaleaf to Expand Patient Education on Medical Cannabis Care in Utah

Insurance payors include Medicare, Utah's largest insurer, Select Health, and Medicaid, providing KindlyMD nearly 70% statewide comprehensive insurance coverage SALT LAKE CITY, UT / ACCESSWIRE / June 5, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced it has received credentialing and is contracted under Utah's top insurance payors, becoming the first alternative medical treatment company in the state to receive this status. Kindly MD, Inc. is currently contracted with Select Health, Medicare, and Medicaid.

KindlyMD Becomes First Utah Alternative Medical Treatment Company to Contract Under State's Top Insurance Payors

SALT LAKE CITY, UT / ACCESSWIRE / June 4, 2024 / KindlyMD, Inc. (NASDAQ:KDLY)(NASDAQ:KDLYW) ("KindlyMD" or "the Company"), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory scheme, today announced that Tim Pickett, Founder and Chief Executive Officer, is scheduled to present at the KCSA Cannabis Virtual Conference on Wednesday, June 5th at 3 p.m. ET. Registration Link: https://bit.ly/3QVIu08 If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available.

KindlyMD to Present at the KCSA Cannabis Virtual Investor Conference on June 5th

JERSEY CITY, N.J. , June 3, 2024 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that KindlyMD, Inc. (NASDAQ: KDLY; KDLYW) a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies has completed its previously announced IPO of 1,240,910 units at a price of $5.50 per Unit for a total of approximately $6.8 million of gross proceeds to the Company, prior to deducting underwriting discounts and offering expenses.

WallachBeth Announces Closing of KindlyMD's $6.8m IPO

SALT LAKE CITY, UT / ACCESSWIRE / June 3, 2024 / KindlyMD, Inc. (NASDAQ:KDLY)(NASDAQ:KDLYW) ("KindlyMD" or the "Company"), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory scheme, today announced the closing of its previously announced initial public offering of 1,240,910 units (each, a "Unit," collectively, the "Units") at a price of $5.50 per Unit for a total of approximately $6.8 million of gross proceeds to the Company, prior to deducting underwriting discounts and offering expenses. Each Unit is comprised of one share of the Company's common stock with $0.001 par value per share ("Common Stock"), one tradeable warrant (each, a "Tradeable Warrant," collectively, the "Tradeable Warrants") to purchase one share of Common Stock at an exercise price of $6.33 per share, and one non-tradeable warrant (each, a "Non-tradeable Warrant," collectively, the "Non-tradeable Warrants") to purchase one-half of one share of Common Stock at an exercise price of $6.33 per share.

KindlyMD Announces Closing of $6.8 Million Initial Public Offering

JERSEY CITY, N.J. , May 31, 2024 /PRNewswire/ -- KindlyMD, Inc. (NASDAQ: KDLY; KDLYW) ("KindlyMD" or the "Company"), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory scheme, today announced the pricing of its initial public offering of 1,240,910 units (each, a "Unit," collectively, the "Units") at a price of $5.50 per Unit for a total of approximately $6.8 million of gross proceeds to the Company.

WallachBeth Capital Announces Pricing of KindlyMD's $6.8 Million IPO

SALT LAKE CITY, UT / ACCESSWIRE / May 31, 2024 / KindlyMD, Inc. (NASDAQ:KDLY)(NASDAQ:KDLYW) ("KindlyMD" or the "Company"), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory scheme, today announced the pricing of its initial public offering of 1,240,910 units (each, a "Unit," collectively, the "Units") at a price of $5.50 per Unit for a total of approximately $6.8 million of gross proceeds to the Company. Each Unit is comprised of one share of the Company's common stock with $0.001 par value per share ("Common Stock"), one tradeable warrant (each, a "Tradeable Warrant," collectively, the "Tradeable Warrants") to purchase one share of Common Stock at an exercise price of $6.33 per share, and one non-tradeable warrant (each, a "Non-tradeable Warrant," collectively, the "Non-tradeable Warrants") to purchase one-half of one share of Common Stock at an exercise price of $6.33 per share.

KindlyMD Announces Pricing of $6.8 Million Initial Public Offering

Kindly MD, Inc. has filed for an IPO to raise $7 million in capital, although the final figure may differ. The company provides specialty outpatient chronic pain treatment services in Utah. Kindly MD's revenue growth is slowing and management lacks experience in growing a multi-state medical clinic practice.

News for Kindly MD Inc Stock (KDLY)